Which medications require light-protected intravenous infusion?
Apr 26, 2023
Source: Cainiu Health
Dr. Yang Shuwen
Introduction
Fleroxacin injection should be stored protected from light and in a tightly closed container to prevent drug denaturation caused by exposure to light. Sodium nitroprusside for injection is light-sensitive and the solution is unstable; therefore, during infusion, the infusion bottle must be wrapped with black paper or aluminum foil to ensure light protection. Micafungin sodium for injection may undergo decomposition of its active components when exposed to light; hence, light protection of the infusion set is required from the time of drug preparation until completion of the infusion.
Medications requiring light-protected intravenous infusion include fleroxacin injection, sodium nitroprusside for injection, micafungin sodium for injection, among others. Detailed analysis is as follows:
1. Fleroxacin Injection
This belongs to the quinolone class of antibacterial agents and must be stored protected from light and in a tightly closed container. During intravenous infusion, it should be administered slowly under light protection to prevent exposure to light, which may cause drug degradation and affect therapeutic efficacy.
2. Sodium Nitroprusside for Injection
This drug is highly light-sensitive and has poor solution stability. Therefore, it should be freshly prepared before infusion, and the infusion bottle should be immediately wrapped with black paper or aluminum foil to ensure light-protected intravenous administration, thus avoiding reduced drug effectiveness.
3. Micafungin Sodium for Injection
Exposure to light can lead to gradual decomposition of the drug's active components. Hence, from preparation through completion of infusion, the infusion container must be shielded from light at all times to prevent direct sunlight exposure.
In addition, carboplatin injection also requires light protection during use. It is recommended to follow medical guidance for proper medication use, and any physical discomfort during infusion should be promptly reported to the physician.
